Literature DB >> 2442621

Predictable acquisition of a new MHC recognition specificity following expression of a transfected T-cell receptor beta-chain gene.

T Saito, R N Germain.   

Abstract

Activation of mature T lymphocytes requires specific corecognition of antigen together with membrane-associated glycoprotein products of the major histocompatibility complex (MHC). This dual specificity is determined by a single receptor structure consisting of a clone-specific alpha beta heterodimer. Because both the alpha and beta subunits possess unique combining-site-containing V regions, it remains an open issue as to what contribution each of the two chains of the receptor makes to the antigen versus MHC recognition specificities of the complete dimer present on any given T cell or in the T-cell pool as a whole. In the present work, we have used DNA-mediated gene transfer to express a new alpha or beta chain in a recipient murine T-cell hybridoma possessing a related antigen but distinct MHC specificity compared to the receptor-gene donor. Our results demonstrate that a beta-gene transfected hybridoma expresses new receptors with a predictable hybrid specificity, establishing that the beta chain has the predominant role in MHC molecule recognition in this model.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2442621     DOI: 10.1038/329256a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  14 in total

1.  CD3+ CD57+ lymphocytes are not likely to be involved in antigen-specific rejection processes in long-term allograft recipients.

Authors:  B Reipert; C Scheuch; A Lukowsky; P Reinke; E Fietze; W D Döcke; G Staffa; S Czerlinksi; R Hetzer; H D Volk
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

2.  Increased numbers of T lymphocytes with gamma delta-positive antigen receptors in a subgroup of individuals with pulmonary sarcoidosis.

Authors:  B Balbi; D R Moller; M Kirby; K J Holroyd; R G Crystal
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

3.  Immunoregulatory activity of the T-cell receptor alpha chain demonstrated by retroviral gene transfer.

Authors:  D R Green; R Bissonnette; H G Zheng; T Onda; F Echeverri; R J Mogil; J K Steele; M Voralia; A Fotedar
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

4.  Elimination of T-cell-receptor beta-chain diversity in transgenic mice restricts antigen-specific but not alloreactive responses.

Authors:  D P O'Brien; C M Baecher-Allan; R P Burns; N Shastri; R K Barth
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

Review 5.  T-cell receptor and autoimmune disease.

Authors:  S Komori; R M Siegel; K Yui; M Katsumata; M I Greene
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

Review 6.  T-cell-mediated autoimmunity: novel techniques to characterize autoreactive T-cell receptors.

Authors:  Klaus Dornmair; Norbert Goebels; Hans-Ulrich Weltzien; Hartmut Wekerle; Reinhard Hohlfeld
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

Review 7.  T cell activation.

Authors:  Jennifer E Smith-Garvin; Gary A Koretzky; Martha S Jordan
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

8.  Bias toward use of a specific T cell receptor beta-chain variable region in a subgroup of individuals with sarcoidosis.

Authors:  D R Moller; K Konishi; M Kirby; B Balbi; R G Crystal
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

9.  Specific inhibition of cell-surface T-cell receptor expression by antisense oligodeoxynucleotides and its effect on the production of an antigen-specific regulatory T-cell factor.

Authors:  H Zheng; B M Sahai; P Kilgannon; A Fotedar; D R Green
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

10.  T cell Receptor Signal Transduction in T lymphocytes.

Authors:  Balachandra K Gorentla; Xiao-Ping Zhong
Journal:  J Clin Cell Immunol       Date:  2012-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.